GLYC

GlycoMimetics Inc

GLYC.US glycomimetics.com + Research + Basket
CIK 0001253689
Employees 4
Phone 240 243 1201
Fiscal year end December
IPO Jan 10, 2014
Address P.O. Box 65, Monrovia, MD, United States, 21770
Price N/A
USD · NASDAQ
52-week range
0.00
0.00
Market Cap
10.13M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
5.23
Div. Yield
N/A
% Institutions
47.77%
% Insiders
2.66%

1 Year

-42.0%

3 Year

-73.8%

10 Year

-97.9%
Description

GlycoMimetics, Inc. engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland.

Actions

Add an action for GLYC.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Ms. Stephanie R. Irish CPA Vice President of Accounting 1971
Mr. Christian B. Dinneen-Long General Counsel & Company Secretary NA
Mr. Bruce Johnson Senior VP & Chief Commercial Officer 1968
Mr. Chinmaya Rath Senior VP & Chief Business Officer 1977
Mr. Shantha Tyavanagimatt Ph.D. Senior Vice President of Technical Operations NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Aug 07, 2024 Public Equities L.P. Invus N/A Sale 614.00 $18.00 $11.05K SEC
Aug 05, 2024 Public Equities L.P. Invus N/A Sale 1.65K $19.00 $31.26K SEC
Aug 01, 2024 Public Equities L.P. Invus N/A Sale 635.00 $22.00 $13.97K SEC
Jul 29, 2024 Public Equities L.P. Invus N/A Sale 3.64K $24.00 $87.34K SEC
Jul 26, 2024 Public Equities L.P. Invus N/A Sale 2.58K $24.00 $61.99K SEC
Jun 20, 2024 Edwin Rock N/A Purchase 1.90K $25.00 $47.50K SEC
Sep 21, 2023 Edwin Rock N/A Purchase 350.00 $138.00 $48.30K SEC
May 17, 2023 Brian M Hahn N/A Sale 37.00 $195.00 $7.22K SEC
May 10, 2023 Daniel M Junius N/A Purchase 300.00 $156.00 $46.80K SEC
May 08, 2023 Bruce S Johnson N/A Purchase 135.00 $157.00 $21.20K SEC
Feb 23, 2023 Public Equities L.P. Invus N/A Purchase 2.00K $175.00 $350.00K SEC
Feb 21, 2023 Public Equities L.P. Invus N/A Purchase 500.00 $185.00 $92.50K SEC
Feb 17, 2023 Public Equities L.P. Invus N/A Purchase 2.00K $171.00 $342.00K SEC
Feb 15, 2023 Public Equities L.P. Invus N/A Purchase 10.00K $216.00 $2.16M SEC
Feb 09, 2023 Public Equities L.P. Invus N/A Purchase 114.00 $324.00 $36.94K SEC
Jan 25, 2023 Scott D Sandell N/A Sale 6.52K $326.00 $2.13M SEC
Jan 05, 2023 Scott D Sandell N/A Sale 713.00 $276.00 $196.79K SEC
Jan 03, 2023 Scott D Sandell N/A Sale 1.75K $299.00 $522.65K SEC
Dec 22, 2022 Edwin Rock N/A Purchase 1.10K $225.00 $247.50K SEC
Nov 14, 2022 Edwin Rock N/A Purchase 1.00K $143.00 $143.00K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Bvf Inc 9.54M Mar 31, 2025 14.79% $0.08 0.00%
Logos Global Management LP 5.40M Mar 31, 2025 8.37% $0.20 0.00%
Adage Capital Partners Gp LLC 5.09M Mar 31, 2025 7.89% $0.00 0.00%
VR Adviser, LLC 3.00M Mar 31, 2025 4.65% $0.05 0.00%
Vanguard Group Inc 2.67M Mar 31, 2025 4.14% $0.00 0.00%
Wellington Management Company LLP 1.37M Mar 31, 2025 2.12% $0.00 -3.05%
BlackRock Inc 726.30K Mar 31, 2025 1.13% $0.00 -0.32%
Jefferies Financial Group Inc 585.00K Mar 31, 2025 0.91% $0.00 38.04%
Geode Capital Management, LLC 571.73K Mar 31, 2025 0.89% $0.00 9.69%
UBS Group AG 465.91K Mar 31, 2025 0.72% $0.00 103.57%
Balyasny Asset Management LLC 382.57K Mar 31, 2025 0.59% $0.00 0.00%
Shay Capital LLC 356.77K Mar 31, 2025 0.55% $0.01 0.00%
State Street Corp 179.27K Mar 31, 2025 0.28% $0.00 0.00%
Northern Trust Corp 116.99K Mar 31, 2025 0.18% $0.00 0.00%
Intellectus Partners, LLC 45.97K Mar 31, 2025 0.07% $0.00 0.00%
IEQ CAPITAL, LLC 38.36K Mar 31, 2025 0.06% $0.00 0.00%
Virtu Financial LLC 36.33K Mar 31, 2025 0.06% $0.00 0.00%
Susquehanna International Group, LLP 30.58K Mar 31, 2025 0.05% $0.00 -24.98%
Group One Trading, LP 24.43K Mar 31, 2025 0.04% $0.00 4.52%
JustInvest LLC 16.94K Mar 31, 2025 0.03% $0.00 -35.61%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Wellington CIF Biotechnology 1.17M 1.82% ▼ 3.54% Mar 31, 2025
2 NT Ext Eq Mkt Indx Fd DC Lend T3 10.09K 0.02% ▲ 0.00% Dec 31, 2024
3 SSgA U.S. Total Market Index Strategy 6.58K 0.01% ▲ 2.19% Mar 31, 2025

Financial Highlights

▼
Market Cap: $10.13M
EBITDA: $-23.76M
PEG Ratio: $0.00
Book Value: $5.23
Earnings/Share: $-46.00
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -73.99%
ROE (TTM): -182.66%
Revenue (TTM): $10.00K
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Valuation Metrics

Enterprise Value: $1.00B
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 64.53M
Shares Float: 645.15K
% Insiders: 2.66%
% Institutions: 47.77%
Short % Float: 0.03%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-35.17K
Gross Profit
subtotal
$-35.17K
SG&A
adjust
$-18.25M
R&D
adjust
$-14.26M
Other Operating Expense
adjust
$-7.53M
Operating Income
subtotal
$-32.51M
Other / Non-Operating Items
adjust
$-5.37M
Net Income
subtotal
$-37.88M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about GLYC.US!